{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:40:00Z","timestamp":1784554800689,"version":"3.55.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Sponsors of the Guideline Workshop are listed in alphabetical order: AstraZeneca Pharmaceuticals LP, Bayer AG, Boehringer Ingelheim International GmbH, Dexcom, Inc., Eli Lilly and Company."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-024-02550-2","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T14:29:06Z","timestamp":1738938546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop"],"prefix":"10.1186","volume":"24","author":[{"given":"Katharine","family":"Barnard-Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadej","family":"Battelino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank C.","family":"Brosius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ceriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"James R.","family":"Gavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Giorgino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Kellerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Koob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Kosiborod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nebojsa","family":"Lalic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Nedungadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Parkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena W.","family":"Rodbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 D.","family":"R\u00f6tzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Ryd\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne Huey-Herng","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard","family":"Standl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta Tendal","family":"Jeppesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Topsever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Olav","family":"Vandvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"2550_CR1","volume-title":"IDF Diabetes Atlas","author":"ID Federation","year":"2021","unstructured":"Federation ID. IDF Diabetes Atlas. 10th ed. Belgium: Brussels; 2021.","edition":"10"},{"key":"2550_CR2","unstructured":"Organization WH. Obesity and overweight. Geneva; 2024."},{"issue":"25","key":"2550_CR3","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","volume":"80","author":"M Vaduganathan","year":"2022","unstructured":"Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: a compass for future health. J Am Coll Cardiol. 2022;80(25):2361\u201371.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2550_CR4","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","volume":"20","author":"A Francis","year":"2024","unstructured":"Francis A, Harhay MN, Ong ACM, Tummalapalli SL, Ortiz A, Fogo AB, et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol. 2024;20(7):473\u201385.","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"2550_CR5","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","volume":"149","author":"SS Martin","year":"2024","unstructured":"Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. 2024 Heart disease and stroke statistics: a report of US and Global Data from the American Heart Association. Circulation. 2024;149(8):e347\u2013913.","journal-title":"Circulation"},{"issue":"1","key":"2550_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41569-021-00645-x","volume":"19","author":"MN Sarkies","year":"2022","unstructured":"Sarkies MN, Jones LK, Gidding SS, Watts GF. Improving clinical practice guidelines with implementation science. Nat Rev Cardiol. 2022;19(1):3\u20134.","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"2550_CR7","doi-asserted-by":"publisher","first-page":"e495","DOI":"10.1016\/S2468-2667(24)00055-0","volume":"9","author":"KR van Daalen","year":"2024","unstructured":"van Daalen KR, Tonne C, Semenza JC, Rocklov J, Markandya A, Dasandi N, et al. The 2024 Europe report of the Lancet countdown on health and climate change: unprecedented warming demands unprecedented action. Lancet Public Health. 2024;9(7):e495\u2013522.","journal-title":"Lancet Public Health"},{"key":"2550_CR8","doi-asserted-by":"publisher","first-page":"1175898","DOI":"10.3389\/fpubh.2023.1175898","volume":"11","author":"X Sun","year":"2023","unstructured":"Sun X, Li X. Editorial: Aging and chronic disease: public health challenge and education reform. Front Public Health. 2023;11:1175898.","journal-title":"Front Public Health"},{"issue":"1","key":"2550_CR9","first-page":"258","volume":"44","author":"F Hill-Briggs","year":"2020","unstructured":"Hill-Briggs F, Adler NE, Berkowitz SA, Chin MH, Gary-Webb TL, Navas-Acien A, et al. Social determinants of health and diabetes: a scientific review. Diabetes Care. 2020;44(1):258\u201379.","journal-title":"Social Determinants Health Diabetes: Sci Rev Diabetes Care"},{"issue":"1","key":"2550_CR10","doi-asserted-by":"publisher","first-page":"e062158","DOI":"10.1136\/bmjopen-2022-062158","volume":"13","author":"T Wang","year":"2023","unstructured":"Wang T, Tan JB, Liu XL, Zhao I. Barriers and enablers to implementing clinical practice guidelines in primary care: an overview of systematic reviews. BMJ Open. 2023;13(1):e062158.","journal-title":"BMJ Open"},{"key":"2550_CR11","unstructured":"Organization WH. Continuity and coordination of care: a practice brief to support implementation of the WHO Framework on integrated people-centred health services. Geneva, Switzerland; 2018."},{"key":"2550_CR12","first-page":"1","volume-title":"Palgrave encyclopedia of the health humanities","author":"M Chiang","year":"2020","unstructured":"Chiang M. Patient-centered care. In: Crawford P, Kadetz P, editors. Palgrave Encyclopedia of the health humanities. Cham: Springer; 2020. pp. 1\u20134."},{"issue":"1","key":"2550_CR13","doi-asserted-by":"publisher","first-page":"2306936","DOI":"10.1080\/13814788.2024.2306936","volume":"30","author":"A Windak","year":"2024","unstructured":"Windak A, Rochfort A, Jacquet J. The revised European definition of general practice\/family medicine. A pivotal role of one health, planetary health and sustainable development goals. Eur J Gen Pract. 2024;30(1):2306936.","journal-title":"Eur J Gen Pract"},{"key":"2550_CR14","unstructured":"Organization WH. People-centred and integrated health services: an overview of the evidence: interim report; 2015."},{"issue":"8","key":"2550_CR15","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s11136-011-0054-x","volume":"21","author":"CF Snyder","year":"2012","unstructured":"Snyder CF, Aaronson NK, Choucair AK, Elliott TE, Greenhalgh J, Halyard MY, et al. Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual Life Res. 2012;21(8):1305\u201314.","journal-title":"Qual Life Res"},{"issue":"2","key":"2550_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3109\/13814788.2010.481018","volume":"16","author":"P Van Royen","year":"2010","unstructured":"Van Royen P, Beyer M, Chevallier P, Eilat-Tsanani S, Lionis C, Peremans L, et al. The research agenda for general practice\/family medicine and primary health care in Europe. Part 3. Results: person centred care, comprehensive and holistic approach. Eur J Gen Pract. 2010;16(2):113\u20139.","journal-title":"Eur J Gen Pract"},{"issue":"11","key":"2550_CR17","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.2337\/dci22-0034","volume":"45","author":"MJ Davies","year":"2022","unstructured":"Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM et al. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2022;45(11):2753\u201386.","journal-title":"Diabetes Care"},{"issue":"39","key":"2550_CR18","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","volume":"44","author":"N Marx","year":"2023","unstructured":"Marx N, Federici M, Sch\u00fctt K, M\u00fcller-Wieland D, Ajjan RA, Antunes MJ, et al. 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023;44(39):4043\u2013140.","journal-title":"Eur Heart J"},{"issue":"4s","key":"2550_CR19","first-page":"S117","volume":"105","author":"KDIGOKCW Group","year":"2024","unstructured":"Group KDIGOKCW. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4s):S117\u2013314.","journal-title":"Kidney Int"},{"issue":"Suppl 7","key":"2550_CR20","first-page":"1","volume":"22","author":"WT Garvey","year":"2016","unstructured":"Garvey WT, Hurley DL, Kushner RF. Patient-centered care of the patient with obesity. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2016;22(Suppl 7):1\u201320.","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"issue":"1","key":"2550_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000496183","volume":"12","author":"D Durrer Schutz","year":"2019","unstructured":"Durrer Schutz D, Busetto L, Dicker D, Farpour-Lambert N, Pryke R, Toplak H, et al. European practical and patient-centred guidelines for adult obesity management in primary care. Obes Facts. 2019;12(1):40\u201366.","journal-title":"Obes Facts"},{"key":"2550_CR22","unstructured":"Administration USFaD. Focus area: patient-reported outcomes and other clinical outcome assessments; 2022."},{"key":"2550_CR23","unstructured":"(EMA) EMA. Patient experience data in EU medicines development and regulatory decison-making. Amsterdam, The Netherlands; 2022."},{"key":"2550_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1477-7525-4-79","volume":"4","author":"Research; U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. USDoHaHSFCfDEaRUSDoHaHSFCfBEa","year":"2006","unstructured":"Research; U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. USDoHaHSFCfDEaRUSDoHaHSFCfBEa. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4:79.","journal-title":"Health Qual Life Outcomes"},{"key":"2550_CR25","unstructured":"(FDA) USFaDA. Patient-reported outcomes measures: use in medical product development to support labeling claims; 2009."},{"issue":"8","key":"2550_CR26","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.7326\/M22-0514","volume":"175","author":"IK El Mikati","year":"2022","unstructured":"El Mikati IK, Khabsa J, Harb T, Khamis M, Agarwal A, Pardo-Hernandez H, et al. A framework for the development of living practice guidelines in health care. Ann Intern Med. 2022;175(8):1154\u201360.","journal-title":"Ann Intern Med"},{"key":"2550_CR27","unstructured":"Administration USFaD. Patient-focused drug development: collecting comprehensive and representative input; 2018."},{"key":"2550_CR28","unstructured":"(EMA) EMA. Including patient preferences and patient-reported outcomes in global development programmes, submissions ansd labels; 2020."},{"key":"2550_CR29","unstructured":"(EMA) EMA. EMA Regulatory Science to 2025\u2014Strategic Reflection. Amsterdam, The Netherlands; 2020."},{"key":"2550_CR30","unstructured":"Administration USFaD. Patient-focused drug development: incorporating clinical outcome assessments into endpoints for regulatory decision-making - Draft Guidance; 2023."},{"issue":"1","key":"2550_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s41687-020-00219-4","volume":"4","author":"S Cruz Rivera","year":"2020","unstructured":"Cruz Rivera S, McMullan C, Jones L, Kyte D, Slade A, Calvert M. The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders. J Patient Rep Outcomes. 2020;4(1):51.","journal-title":"J Patient Rep Outcomes"},{"key":"2550_CR32","unstructured":"(WHO) WHO. Constitution of th World Health Organization; 1946."},{"issue":"11","key":"2550_CR33","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1016\/j.mayocp.2019.04.005","volume":"94","author":"R Warsame","year":"2019","unstructured":"Warsame R, D\u2019Souza A. Patient reported outcomes have arrived: a practical overview for clinicians in using patient reported outcomes in oncology. Mayo Clin Proc. 2019;94(11):2291\u2013301.","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"2550_CR34","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s11136-021-02951-w","volume":"31","author":"L Van Wilder","year":"2022","unstructured":"Van Wilder L, Devleesschauwer B, Clays E, De Buyser S, Van der Heyden J, Charafeddine R, et al. The impact of multimorbidity patterns on health-related quality of life in the general population: results of the Belgian health interview survey. Qual Life Res. 2022;31(2):551\u201365.","journal-title":"Qual Life Res"},{"issue":"8","key":"2550_CR35","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1007\/s00125-023-05926-3","volume":"66","author":"CB Terwee","year":"2023","unstructured":"Terwee CB, Elders PJM, Blom MT, Beulens JW, Rolandsson O, Rogge AA, et al. Patient-reported outcomes for people with diabetes: What and how to measure? A narrative review. Diabetologia. 2023;66(8):1357\u201377.","journal-title":"Diabetologia"},{"issue":"3","key":"2550_CR36","doi-asserted-by":"publisher","first-page":"e15219","DOI":"10.1111\/dme.15219","volume":"41","author":"RC Kelly","year":"2024","unstructured":"Kelly RC, Holt RIG, Desborough L, Majidi S, Town M, Naranjo D, et al. The psychosocial burdens of living with diabetes. Diabet Med J Br Diabet Assoc. 2024;41(3):e15219.","journal-title":"Diabet Med J Br Diabet Assoc"},{"issue":"12","key":"2550_CR37","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1111\/dme.14286","volume":"37","author":"J Nano","year":"2020","unstructured":"Nano J, Carinci F, Okunade O, Whittaker S, Walbaum M, Barnard-Kelly K, et al. A standard set of person-centred outcomes for diabetes mellitus: results of an international and unified approach. Diabet Med J Br Diabet Assoc. 2020;37(12):2009\u201318.","journal-title":"Diabet Med J Br Diabet Assoc"},{"issue":"12","key":"2550_CR38","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.2337\/dc16-2053","volume":"39","author":"D Young-Hyman","year":"2016","unstructured":"Young-Hyman D, de Groot M, Hill-Briggs F, Gonzalez JS, Hood K, Peyrot M. Psychosocial care for people with diabetes: a position Statement of the American Diabetes Association. Diabetes Care. 2016;39(12):2126\u201340.","journal-title":"Diabetes Care"},{"key":"2550_CR39","doi-asserted-by":"publisher","first-page":"107933","DOI":"10.1016\/j.pec.2023.107933","volume":"116","author":"K Hamilton","year":"2023","unstructured":"Hamilton K, Forde R, Due-Christensen M, Eeg-Olofson K, Nathanson D, Rossner S, et al. Which diabetes specific patient reported outcomes should be measured in routine care? A systematic review to inform a core outcome set for adults with type 1 and 2 diabetes mellitus: the European Health Outcomes Observatory (H2O) programme. Patient Educ Couns. 2023;116:107933.","journal-title":"Patient Educ Couns"},{"issue":"5","key":"2550_CR40","doi-asserted-by":"publisher","first-page":"e15259","DOI":"10.1111\/dme.15259","volume":"41","author":"AK Porth","year":"2024","unstructured":"Porth AK, Huberts AS, Rogge A, B\u00e9nard AHM, Forbes A, Strootker A, et al. Standardising personalised diabetes care across European health settings: a person-centred outcome set agreed in a multinational Delphi study. Diabet Med J Br Diabet Assoc. 2024;41(5):e15259.","journal-title":"Diabet Med J Br Diabet Assoc"},{"issue":"8","key":"2550_CR41","doi-asserted-by":"publisher","first-page":"e15332","DOI":"10.1111\/dme.15332","volume":"41","author":"K Barnard-Kelly","year":"2024","unstructured":"Barnard-Kelly K, Marrero D, de Wit M, Pouwer F, Khunti K, Hermans N et al. Towards the standardisation of adult person-reported outcome domains in diabetes research: a Consensus Statement development panel. Diabet Med. 2024;41(8):e15332.","journal-title":"Diabet Med"},{"key":"2550_CR42","unstructured":"Butland B. Foresight. Tackling obesities: future choices-project report. In: Science GOf, editor. Lonodon, United Kingdom; 2007."},{"issue":"10","key":"2550_CR43","doi-asserted-by":"publisher","first-page":"e13494","DOI":"10.1111\/obr.13494","volume":"23","author":"B Talumaa","year":"2022","unstructured":"Talumaa B, Brown A, Batterham RL, Kalea AZ. Effective strategies in ending weight stigma in healthcare. Obes Rev. 2022;23(10):e13494.","journal-title":"Obes Rev"},{"issue":"5","key":"2550_CR44","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/jan.13511","volume":"74","author":"YK Wu","year":"2018","unstructured":"Wu YK, Berry DC. Impact of weight stigma on physiological and psychological health outcomes for overweight and obese adults: a systematic review. J Adv Nurs. 2018;74(5):1030\u201342.","journal-title":"J Adv Nurs"},{"key":"2550_CR45","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.appet.2016.02.032","volume":"102","author":"KS O\u2019Brien","year":"2016","unstructured":"O\u2019Brien KS, Latner JD, Puhl RM, Vartanian LR, Giles C, Griva K, et al. The relationship between weight stigma and eating behavior is explained by weight bias internalization and psychological distress. Appetite. 2016;102:70\u20136.","journal-title":"Appetite"},{"issue":"1","key":"2550_CR46","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40337-023-00959-w","volume":"12","author":"T Foster","year":"2024","unstructured":"Foster T, Eaton M, Probst Y. The relationship between internalised weight bias and biopsychosocial outcomes in children and youth: a systematic review. J Eat Disord. 2024;12(1):38.","journal-title":"J Eat Disord"},{"issue":"8","key":"2550_CR47","doi-asserted-by":"publisher","first-page":"e13452","DOI":"10.1111\/obr.13452","volume":"23","author":"CEE de Vries","year":"2022","unstructured":"de Vries CEE, Terwee CB, Al Nawas M, van Wagensveld BA, Janssen IMC, Liem RSL, et al. Outcomes of the first global multidisciplinary consensus meeting including persons living with obesity to standardize patient-reported outcome measurement in obesity treatment research. Obes Rev. 2022;23(8):e13452.","journal-title":"Obes Rev"},{"issue":"11","key":"2550_CR48","doi-asserted-by":"publisher","first-page":"e5401","DOI":"10.1097\/GOX.0000000000005401","volume":"11","author":"F Dalaei","year":"2023","unstructured":"Dalaei F, de Vries CEE, Cano SJ, Kaur MN, Poulsen L, Pfob A, et al. BODY-Q normative scores: psychometric validation of the BODY-Q in the general population in Europe and North America. Plast Reconstr Surg Glob Open. 2023;11(11):e5401.","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"2","key":"2550_CR49","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/ehjqcco\/qcab051","volume":"9","author":"R Kornowski","year":"2021","unstructured":"Kornowski R. Patient-reported outcome measures in cardiovascular disease. Eur Heart J Qual Care Clin Outcomes. 2021;9(2):119\u201327.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"36","key":"2550_CR50","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1093\/eurheartj\/ehad514","volume":"44","author":"P Moons","year":"2023","unstructured":"Moons P, Norekv\u00e5l TM, Arbelo E, Borregaard B, Casadei B, Cosyns B, et al. Placing patient-reported outcomes at the centre of cardiovascular clinical practice: implications for quality of care and management. Eur Heart J. 2023;44(36):3405\u201322.","journal-title":"Eur Heart J"},{"issue":"2","key":"2550_CR51","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/ejhf.1100","volume":"20","author":"W Doehner","year":"2018","unstructured":"Doehner W, Ural D, Haeusler KG, \u010celutkien\u0117 J, Bestetti R, Cavusoglu Y, et al. Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy. A position paper from the Study Group on Heart and Brain Interaction of the heart failure association. Eur J Heart Fail. 2018;20(2):199\u2013215.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"2550_CR52","doi-asserted-by":"publisher","first-page":"e009677","DOI":"10.1161\/CIRCOUTCOMES.122.009677","volume":"16","author":"C Brown-Johnson","year":"2023","unstructured":"Brown-Johnson C, Calma J, Amano A, Winget M, Harris SR, Vilendrer S, et al. Evaluating the implementation of patient-reported outcomes in heart failure clinic: a qualitative assessment. Circ Cardiovasc Qual Outcomes. 2023;16(5):e009677.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"20","key":"2550_CR53","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1016\/j.jacc.2020.09.542","volume":"76","author":"JA Spertus","year":"2020","unstructured":"Spertus JA, Jones PG, Sandhu AT, Arnold SV. Interpreting the Kansas City cardiomyopathy questionnaire in clinical trials and clinical care: JACC state-of-the-art review. J Am Coll Cardiol. 2020;76(20):2379\u201390.","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"2550_CR54","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice guidelines. Circulation. 2022;145(18):e895\u20131032.","journal-title":"Circulation"},{"issue":"20","key":"2550_CR55","doi-asserted-by":"publisher","first-page":"e1176","DOI":"10.1161\/CIR.0000000000001233","volume":"149","author":"MJ Goldfarb","year":"2024","unstructured":"Goldfarb MJ, Saylor MA, Bozkurt B, Code J, Di Palo KE, Durante A, et al. Patient-centered adult cardiovascular care: a scientific statement from the American Heart Association. Circulation. 2024;149(20):e1176\u201388.","journal-title":"Circulation"},{"issue":"5","key":"2550_CR56","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cardfail.2022.02.010","volume":"28","author":"M Writing Committee","year":"2022","unstructured":"Writing Committee M, Members AAJC. 2022 AHA\/ACC\/HFSA Guideline for the management of heart failure. J Card Fail. 2022;28(5):e1\u2013167.","journal-title":"J Card Fail"},{"issue":"5","key":"2550_CR57","doi-asserted-by":"publisher","first-page":"e067386","DOI":"10.1136\/bmjopen-2022-067386","volume":"13","author":"N Tangri","year":"2023","unstructured":"Tangri N, Moriyama T, Schneider MP, Virgitti JB, De Nicola L, Arnold M, et al. Prevalence of undiagnosed stage 3 chronic kidney disease in France, Germany, Italy, Japan and the USA: results from the multinational observational REVEAL-CKD study. BMJ Open. 2023;13(5):e067386.","journal-title":"BMJ Open"},{"issue":"3","key":"2550_CR58","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1053\/j.ajkd.2018.10.007","volume":"73","author":"WR Verberne","year":"2019","unstructured":"Verberne WR, Das-Gupta Z, Allegretti AS, Bart HAJ, van Biesen W, Garc\u00eda-Garc\u00eda G, et al. Development of an international standard set of value-based outcome measures for patients with chronic kidney disease: a report of the International Consortium for Health Outcomes Measurement (ICHOM) CKD Working Group. Am J Kidney Dis Off J Natl Kidney Found. 2019;73(3):372\u201384.","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"4","key":"2550_CR59","doi-asserted-by":"publisher","first-page":"e1003954","DOI":"10.1371\/journal.pmed.1003954","volume":"19","author":"BR Fletcher","year":"2022","unstructured":"Fletcher BR, Damery S, Aiyegbusi OL, Anderson N, Calvert M, Cockwell P, et al. Symptom burden and health-related quality of life in chronic kidney disease: a global systematic review and meta-analysis. PLoS Med. 2022;19(4):e1003954.","journal-title":"PLoS Med"},{"key":"2550_CR60","doi-asserted-by":"crossref","unstructured":"Carrero JJ, Pollock C, Kanda E, Lam C, Ofori-Asenso R, Chen T et al. #3393 Patient-reported outcomes in early versus advanced chronic kidney disease: evidence from baseline data in the discover CKD prospective study. Nephrol Dialysis Transplantation. 2023;38(Supplement_1).","DOI":"10.1093\/ndt\/gfad063c_3393"},{"issue":"4","key":"2550_CR61","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.ekir.2021.01.038","volume":"6","author":"M Metzger","year":"2021","unstructured":"Metzger M, Abdel-Rahman EM, Boykin H, Song MK. A narrative review of management strategies for common symptoms in Advanced CKD. Kidney Int Rep. 2021;6(4):894\u2013904.","journal-title":"Kidney Int Rep"},{"issue":"4","key":"2550_CR62","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1681\/ASN.2018100994","volume":"30","author":"JD Peipert","year":"2019","unstructured":"Peipert JD, Nair D, Klicko K, Schatell DR, Hays RD. Kidney disease quality of life 36-Item short form survey (KDQOL-36) normative values for the United States dialysis population and new single summary score. J Am Soc Nephrol. 2019;30(4):654\u201363.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2550_CR63","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s11255-023-03702-1","volume":"56","author":"Y Shi","year":"2024","unstructured":"Shi Y, Pu S, Peng H, Luo Y. Development and validation of the patient-reported outcome scale for chronic kidney disease. Int Urol Nephrol. 2024;56(2):653\u201365.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"2550_CR64","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12911-021-01624-5","volume":"21","author":"CB Terwee","year":"2021","unstructured":"Terwee CB, Zuidgeest M, Vonkeman HE, Cella D, Haverman L, Roorda LD. Common patient-reported outcomes across ICHOM Standard sets: the potential contribution of PROMIS\u00ae. BMC Med Inf Decis Mak. 2021;21(1):259.","journal-title":"BMC Med Inf Decis Mak"},{"issue":"1","key":"2550_CR65","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/imj.14355","volume":"50","author":"CAE Bachmeier","year":"2020","unstructured":"Bachmeier CAE, Waugh C, Vitanza M, Bowden T, Uhlman C, Hurst C, et al. Diabetes care: addressing psychosocial well-being in young adults with a newly developed assessment tool. Intern Med J. 2020;50(1):70\u20136.","journal-title":"Intern Med J"},{"key":"2550_CR66","doi-asserted-by":"publisher","first-page":"100020","DOI":"10.1016\/j.jadr.2020.100020","volume":"1","author":"PE Sischka","year":"2020","unstructured":"Sischka PE, Costa AP, Steffgen G, Schmidt AF. The WHO-5 well-being index\u2014validation based on item response theory and the analysis of measurement invariance across 35 countries. J Affect Disorders Rep. 2020;1:100020.","journal-title":"J Affect Disorders Rep"},{"issue":"9","key":"2550_CR67","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"issue":"5","key":"2550_CR68","doi-asserted-by":"publisher","first-page":"760","DOI":"10.2337\/diacare.20.5.760","volume":"20","author":"GW Welch","year":"1997","unstructured":"Welch GW, Jacobson AM, Polonsky WH. The problem areas in diabetes scale. An evaluation of its clinical utility. Diabetes Care. 1997;20(5):760\u20136.","journal-title":"Diabetes Care"},{"issue":"2","key":"2550_CR69","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/oby.2001.13","volume":"9","author":"RL Kolotkin","year":"2001","unstructured":"Kolotkin RL, Crosby RD, Kosloski KD, Williams GR. Development of a brief measure to assess quality of life in obesity. Obes Res. 2001;9(2):102\u201311.","journal-title":"Obes Res"},{"issue":"4","key":"2550_CR70","doi-asserted-by":"publisher","first-page":"e679","DOI":"10.1097\/GOX.0000000000000665","volume":"4","author":"AF Klassen","year":"2016","unstructured":"Klassen AF, Cano SJ, Alderman A, Soldin M, Thoma A, Robson S, et al. The BODY-Q: a patient-reported outcome instrument for weight loss and body contouring treatments. Plast Reconstr Surg Glob Open. 2016;4(4):e679.","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"6","key":"2550_CR71","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1161\/CIRCHEARTFAILURE.113.000359","volume":"6","author":"SM Joseph","year":"2013","unstructured":"Joseph SM, Novak E, Arnold SV, Jones PG, Khattak H, Platts AE, et al. Comparable performance of the Kansas City cardiomyopathy questionnaire in patients with heart failure with preserved and reduced ejection fraction. Circ Heart Fail. 2013;6(6):1139\u201346.","journal-title":"Circ Heart Fail"},{"issue":"8","key":"2550_CR72","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jchf.2022.03.002","volume":"10","author":"M Nassif","year":"2022","unstructured":"Nassif M, Fine JT, Dolan C, Reaney M, Addepalli P, Allen VD, et al. Validation of the Kansas City cardiomyopathy questionnaire in symptomatic obstructive hypertrophic cardiomyopathy. JACC Heart Fail. 2022;10(8):531\u20139.","journal-title":"JACC Heart Fail"},{"issue":"5","key":"2550_CR73","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0735-1097(00)00531-3","volume":"35","author":"CP Green","year":"2000","unstructured":"Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City cardiomyopathy questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000;35(5):1245\u201355.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2550_CR74","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1007\/s11136-013-0383-z","volume":"22","author":"O Garin","year":"2013","unstructured":"Garin O, Ferrer M, Pont A, Wiklund I, Van Ganse E, Vilagut G, et al. Evidence on the global measurement model of the Minnesota living with heart failure questionnaire. Qual Life Res. 2013;22(10):2675\u201384.","journal-title":"Qual Life Res"},{"issue":"2","key":"2550_CR75","first-page":"202","volume":"23","author":"AC Ricardo","year":"2013","unstructured":"Ricardo AC, Hacker E, Lora CM, Ackerson L, DeSalvo KB, Go A, et al. Validation of the kidney disease quality of life short form 36 (KDQOL-36) US Spanish and English versions in a cohort of hispanics with chronic kidney disease. Ethn Dis. 2013;23(2):202\u20139.","journal-title":"Ethn Dis"},{"issue":"5","key":"2550_CR76","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/BF00451725","volume":"3","author":"RD Hays","year":"1994","unstructured":"Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res. 1994;3(5):329\u201338.","journal-title":"Qual Life Res"},{"issue":"5","key":"2550_CR77","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1023\/A:1015631411960","volume":"11","author":"JC Korevaar","year":"2002","unstructured":"Korevaar JC, Merkus MP, Jansen MA, Dekker FW, Boeschoten EW, Krediet RT, et al. Validation of the KDQOL-SF: a dialysis-targeted health measure. Qual Life Res. 2002;11(5):437\u201347.","journal-title":"Qual Life Res"},{"issue":"11","key":"2550_CR78","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","volume":"63","author":"D Cella","year":"2010","unstructured":"Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, et al. The patient-reported outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005\u20132008. J Clin Epidemiol. 2010;63(11):1179\u201394.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"2550_CR79","doi-asserted-by":"publisher","first-page":"e0267030","DOI":"10.1371\/journal.pone.0267030","volume":"17","author":"L Carfora","year":"2022","unstructured":"Carfora L, Foley CM, Hagi-Diakou P, Lesty PJ, Sandstrom ML, Ramsey I, et al. Patients\u2019 experiences and perspectives of patient-reported outcome measures in clinical care: a systematic review and qualitative meta-synthesis. PLoS ONE. 2022;17(4):e0267030.","journal-title":"PLoS ONE"},{"issue":"6","key":"2550_CR80","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/s41591-024-02909-8","volume":"30","author":"NL Crossnohere","year":"2024","unstructured":"Crossnohere NL, Anderson N, Baumhauer J, Calvert M, Esparza R, Gulbransen S, et al. A framework for implementing patient-reported outcomes in clinical care: the PROTEUS-practice guide. Nat Med. 2024;30(6):1519\u201320.","journal-title":"Nat Med"},{"issue":"14","key":"2550_CR81","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1200\/JCO.2013.53.5948","volume":"32","author":"G Kotronoulas","year":"2014","unstructured":"Kotronoulas G, Kearney N, Maguire R, Harrow A, Di Domenico D, Croy S, et al. What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol. 2014;32(14):1480\u2013501.","journal-title":"J Clin Oncol"},{"issue":"2","key":"2550_CR82","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s00520-021-06545-7","volume":"30","author":"YT Cheung","year":"2022","unstructured":"Cheung YT, Chan A, Charalambous A, Darling HS, Eng L, Grech L, et al. The use of patient-reported outcomes in routine cancer care: preliminary insights from a multinational scoping survey of oncology practitioners. Support Care Cancer. 2022;30(2):1427\u201339.","journal-title":"Support Care Cancer"},{"key":"2550_CR83","unstructured":"(ISOQOL) ISfQoLR. User\u2019s guide to implementing patient- reported outcomes assessment in clinical practice, version 2; 2015."},{"issue":"3","key":"2550_CR84","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s11136-018-2048-4","volume":"28","author":"EKH Chan","year":"2019","unstructured":"Chan EKH, Edwards TC, Haywood K, Mikles SP, Newton L. Implementing patient-reported outcome measures in clinical practice: a companion guide to the ISOQOL user\u2019s guide. Qual Life Res. 2019;28(3):621\u20137.","journal-title":"Qual Life Res"},{"issue":"12","key":"2550_CR85","doi-asserted-by":"publisher","first-page":"584","DOI":"10.5312\/wjo.v11.i12.584","volume":"11","author":"DF Hamilton","year":"2020","unstructured":"Hamilton DF, Giesinger JM, Giesinger K. Technological developments enable measuring and using patient-reported outcomes data in orthopaedic clinical practice. World J Orthop. 2020;11(12):584\u201394.","journal-title":"World J Orthop"},{"issue":"7","key":"2550_CR86","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1093\/rheumatology\/kez506","volume":"59","author":"SJ Bartlett","year":"2020","unstructured":"Bartlett SJ, De Leon E, Orbai AM, Haque UJ, Manno RL, Ruffing V, et al. Patient-reported outcomes in RA care improve patient communication, decision-making, satisfaction and confidence: qualitative results. Rheumatology. 2020;59(7):1662\u201370.","journal-title":"Rheumatology"},{"issue":"9","key":"2550_CR87","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/annonc\/mdv181","volume":"26","author":"D Howell","year":"2015","unstructured":"Howell D, Molloy S, Wilkinson K, Green E, Orchard K, Wang K, et al. Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors. Ann Oncol. 2015;26(9):1846\u201358.","journal-title":"Ann Oncol"},{"issue":"9","key":"2550_CR88","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.annonc.2022.04.007","volume":"33","author":"M Di Maio","year":"2022","unstructured":"Di Maio M, Basch E, Denis F, Fallowfield LJ, Ganz PA, Howell D, et al. The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline. Ann Oncol. 2022;33(9):878\u201392.","journal-title":"Ann Oncol"},{"issue":"7","key":"2550_CR89","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/dme.12245","volume":"30","author":"A Nicolucci","year":"2013","unstructured":"Nicolucci A, Kovacs Burns K, Holt RI, Comaschi M, Hermanns N, Ishii H, et al. Diabetes attitudes, wishes and needs second study (DAWN2\u2122): cross-national benchmarking of diabetes-related psychosocial outcomes for people with diabetes. Diabet Med J Br Diabet Assoc. 2013;30(7):767\u201377.","journal-title":"Diabet Med J Br Diabet Assoc"},{"key":"2550_CR90","doi-asserted-by":"crossref","unstructured":"Torbj\u00f8rnsen A, Jensen AL, Singstad T, Weldingh NM, Holmen H. Patient-reported outcome measures in diabetes outpatient care: a scoping review. BMJ Open Diabetes Res Care. 2023;11(6).","DOI":"10.1136\/bmjdrc-2023-003628"},{"issue":"5","key":"2550_CR91","doi-asserted-by":"publisher","first-page":"e14791","DOI":"10.1111\/dme.14791","volume":"39","author":"T Laurberg","year":"2022","unstructured":"Laurberg T, Schougaard LMV, Hjollund NHI, Lomborg KE, Hansen TK, Jensen AL. Randomized controlled study to evaluate the impact of flexible patient-controlled visits in people with type 1 diabetes: the DiabetesFlex Trial. Diabet Med J Br Diabet Assoc. 2022;39(5):e14791.","journal-title":"Diabet Medicine: J Br Diabet Association"},{"issue":"3","key":"2550_CR92","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/scs.13154","volume":"37","author":"AL Jensen","year":"2023","unstructured":"Jensen AL, Schougaard LMV, Laurberg T, Hansen TK, Lomborg K. Flexible patient-reported outcome-based telehealth follow-up for type 1 diabetes: a qualitative study. Scand J Caring Sci. 2023;37(3):662\u201376.","journal-title":"Scand J Caring Sci"},{"issue":"11","key":"2550_CR93","doi-asserted-by":"publisher","first-page":"e28329","DOI":"10.2196\/28329","volume":"5","author":"SE Skovlund","year":"2021","unstructured":"Skovlund SE, Troelsen LH, Noergaard LM, Pietraszek A, Jakobsen PE, Ejskjaer N. Feasibility and acceptability of a digital patient-reported outcome tool in routine outpatient diabetes care: mixed methods formative pilot study. JMIR Form Res. 2021;5(11):e28329.","journal-title":"JMIR Form Res"},{"issue":"6","key":"2550_CR94","doi-asserted-by":"publisher","first-page":"e14535","DOI":"10.1111\/dme.14535","volume":"38","author":"I Hernar","year":"2021","unstructured":"Hernar I, Graue M, Strandberg RB, Lie SS, Sigurdardottir AK, Richards DA, et al. Young adults with type 1 diabetes and their experiences with diabetes follow-up and participation in the DiaPROM pilot trial: a qualitative study. Diabet Med J Br Diabet Assoc. 2021;38(6):e14535.","journal-title":"Diabet Med J Br Diabet Assoc"},{"issue":"4","key":"2550_CR95","doi-asserted-by":"publisher","first-page":"e042353","DOI":"10.1136\/bmjopen-2020-042353","volume":"11","author":"I Hernar","year":"2021","unstructured":"Hernar I, Graue M, Richards DA, Strandberg RB, Nilsen RM, Rekdal M, et al. Use of patient-reported outcome measures (PROMs) in clinical diabetes consultations: the DiaPROM randomised controlled pilot trial. BMJ Open. 2021;11(4):e042353.","journal-title":"BMJ Open"},{"key":"2550_CR96","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40814-019-0419-4","volume":"5","author":"I Hernar","year":"2019","unstructured":"Hernar I, Graue M, Richards D, Strandberg RB, Nilsen RM, Tell GS, et al. Electronic capturing of patient-reported outcome measures on a touchscreen computer in clinical diabetes practice (the DiaPROM trial): a feasibility study. Pilot Feasibility Stud. 2019;5:29.","journal-title":"Pilot Feasibility Stud"},{"issue":"6","key":"2550_CR97","doi-asserted-by":"publisher","first-page":"e14419","DOI":"10.1111\/dme.14419","volume":"38","author":"A Haugstvedt","year":"2021","unstructured":"Haugstvedt A, Hernar I, Graue M, Strandberg RB, Stangeland Lie S, Sigurdardottir AK, et al. Nurses\u2019 and physicians\u2019 experiences with diabetes consultations and the use of dialogue tools in the DiaPROM pilot trial: a qualitative study. Diabet Med J Br Diabet Assoc. 2021;38(6):e14419.","journal-title":"Diabet Med J Br Diabet Assoc"},{"issue":"1","key":"2550_CR98","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13584-024-00592-1","volume":"13","author":"N Abdel-Rahman","year":"2024","unstructured":"Abdel-Rahman N, Manor O, Elran E, Siscovick D, Calderon-Margalit R. Implications of patient-reported outcome measures among patients with recently diagnosed type 2 diabetes. Isr J Health Policy Res. 2024;13(1):6.","journal-title":"Isr J Health Policy Res"},{"issue":"1","key":"2550_CR99","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s41687-024-00724-w","volume":"8","author":"BMP Mourits","year":"2024","unstructured":"Mourits BMP, den Hartog SJ, de Graaf JA, Roozenbeek B, Post MWM, Visser-Meily JMA, et al. Exploring patients\u2019 experience using PROMs within routine post-discharge follow-up assessment after stroke: a mixed methods approach. J Patient Rep Outcomes. 2024;8(1):46.","journal-title":"J Patient Rep Outcomes"},{"issue":"6","key":"2550_CR100","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1007\/s11136-021-03003-z","volume":"31","author":"R Campbell","year":"2022","unstructured":"Campbell R, Ju A, King MT, Rutherford C. Perceived benefits and limitations of using patient-reported outcome measures in clinical practice with individual patients: a systematic review of qualitative studies. Qual Life Res. 2022;31(6):1597\u2013620.","journal-title":"Qual Life Res"},{"issue":"1","key":"2550_CR101","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12913-024-10707-8","volume":"24","author":"T Kaneyasu","year":"2024","unstructured":"Kaneyasu T, Hoshino E, Naito M, Suzukamo Y, Miyazaki K, Kojima S, et al. How to select and understand guidelines for patient-reported outcomes: a scoping review of existing guidance. BMC Health Serv Res. 2024;24(1):334.","journal-title":"BMC Health Serv Res"},{"issue":"7650","key":"2550_CR102","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (Clinical Res Ed). 2008;336(7650):924\u20136.","journal-title":"BMJ (Clinical Res Ed)"},{"key":"2550_CR103","first-page":"f167","volume":"346","author":"N Black","year":"2013","unstructured":"Black N. Patient reported outcome measures could help transform healthcare. BMJ (Clinical Res ed). 2013;346:f167.","journal-title":"BMJ (Clinical Res Ed)"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02550-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-024-02550-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02550-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T14:29:17Z","timestamp":1738938557000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-024-02550-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2550"],"URL":"https:\/\/doi.org\/10.1186\/s12933-024-02550-2","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"8 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Katharine Barnard-Kelly is founder and shareholder at Spotlight-AQ Ltd. KBK has received research support from Dexcom, Embecta, JDRF, Novo Nordisk and Roche Diabetes Care, and honoraria from Sanofi. Tadej Battelino has served on the advisory boards of Abbott, Boehringer Ingelheim, Dreamed Diabetes, Eli Lilly and Company, Indigo Diabetes, Medtronic, Novo Nordisk, and Sanofi. TB has received speaker\u2019s bureau honoraria from Abbott, Eli Lilly and Company, Medtronic, Novo Nordisk, Roche, and Sanofi. The University Medical Center has received research grant support from Abbott, GluSense, Medtronic, Novo Nordisk, Sandoz, Sanofi, and Zealand Pharma. Frank C. Brosius is a consultant for MAKSCIENTIFIC. Antonio Ceriello reports consulting and speaking for Bayer, Berlin-Chemie, Eli Lilly and Company, Guidotti, Merck, Novo Nordisk, Roche Diagnostics and Sanofi. Francesco Cosentino has nothing reported. Julian Elliott has nothing reported. James R. Gavin III has served on the advisory boards of Abbott Diabetes Care and Embecta, and on the speaker\u2019s bureaus of Boehringer Ingelheim and Eli Lilly and Company. Francesco Giorgino has served on the advisory boards of AstraZeneca, Eli Lilly and Company, Novo Nordisk, Roche Diabetes Care, Sanofi and as a consultant to AstraZeneca, Boehringer Ingelheim, LifeScan, Medimmune, Medtronic, Merck Sharp & Dohme, Roche Diabetes Care and Sanofi. FG has also received research support from Eli Lilly and Company and Roche Diabetes Care. Jennifer Green has nothing reported. Linong Ji declares that he has no competing interests. Monika Kellerer has served on advisory boards of Abbott Diabetes Care, Astra Zeneca, Bayer AG, Boehringer-Ingelheim, Eli Lilly, NovoNordisk and Sanofi. Sue Koob has nothing reported. Mikhail Kosiborod reports consulting or advisory board participation for 35Pharma, Alnylam Pharmaceuticals, Amgen, Applied Therapeutics, AstraZeneca, Bayer, Boehringer Ingelheim, Cytokinetics, Dexcom, Eli Lilly and Company, Esperion Therapeutics, Janssen Pharmaceuticals, Lexicon Pharmaceuticals, Merck (Diabetes and Cardiovascular), Novo Nordisk, Pharmacosmos, Pfizer, scPharmaceuticals, Sanofi, Structure Therapeutics, Vifor Pharma and Youngene Therapeutics. MK has also received honoraria from AstraZeneca, Boehringer Ingelheim and Novo Nordisk, and research grants from AstraZeneca, Boehringer Ingelheim and Pfizer. Nebojsa Lalic declares that he has no competing interests. Nikolaus Marx has received research grants from Boehringer Ingelheim and MSD, speaking fees form Amgen, AstraZeneca, Bayer, BMS, Boehringer Ingelheim, Eli Lilly and Company, MSD, Novo Nordisk, and Sanofi-Aventis and has served or serves on the advisory board of Amgen, Bayer, BMS, Boehringer Ingelheim, MSD, Novo Nordisk, and Sanofi-Aventis. Prashant Nedungadi has nothing reported. Christopher G. Parkin has nothing reported. Helena W. Rodbard declares that she has no competing interests. Ren\u00e9 D. R\u00f6tzer is employee of Sciarc GmbH. Lars Ryd\u00e9n declares that he has no competing interests related to this work. Wayne Sheu has nothing reported. Eberhard Standl declares that he has no competing interests. Britta Tendal Jeppesen declares that she has no competing interests. Pinar Topsever has received honoraria or consulting fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, and LifeScan, and has served on the speaker\u2019s bureau for AstraZeneca. PT received grant\/research support from PCDE, made possible by corporate sponsorship from AstraZeneca, Eli Lilly, Novo Nordisk, and Roche Diagnostics; the sponsors had no input into the study protocols. Per Olav Vandvik has nothing reported. Christoph Wanner received honoraria for steering committee and adboard participation as well as lecturing from Alexion, AstraZeneca, Bayer, Boehringer Ingelheim, Eli-Lilly, MSD, Novo Nordisk and Sanofi. Oliver Schnell is founder and CEO at Sciarc GmbH, Baierbrunn, Germany.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}